Mc. Levesque et Bf. Haynes, IN-VITRO CULTURE OF HUMAN PERIPHERAL-BLOOD MONOCYTES INDUCES HYALURONAN-BINDING AND UP-REGULATES MONOCYTE VARIANT CD44 ISOFORM EXPRESSION, The Journal of immunology, 156(4), 1996, pp. 1557-1565
CD44 is a cell surface proteoglycan homologous to cartilage link prote
in that serves as a receptor for hyaluronan (HA). CD44 isoforms includ
e an unspliced 80- to 90-kDa standard form (CD44S) and isoforms derive
d from alternative splicing of nine CD44 variant exons (CD44V). Ligati
on of CD44 isoforms on monocytes induces the production of IL-1 and TN
F-alpha. In addition, CD44 mAbs and HA inhibit HIV infection of monocy
tes by monocytotropic HIV, but do not inhibit T cell tropic HIV infect
ivity of T cells. To determine the ability of PB lymphocytes and monoc
ytes to bind HA and to define and compare CD44 isoforms present on PB
monocytes and lymphocytes, we studied PBMC using a panel of CD44 mAbs,
HA-FITC, flow cytometry, and Western blot analysis. We found that fre
shly isolated PB monocytes and lymphocytes did not bind soluble HA. Ho
wever, in vitro culture of PBMC for 8 to 16 h resulted in CD44-depende
nt HA-FITC binding to monocytes, but not to lymphocytes. Western blot
and flow cytometry analyses using CD44 mAbs demonstrated selective exp
ression of high m.w. CD44V isoforms on cultured monocytes, but not on
lymphocytes. Finally, tissue macrophages and multinucleated giant cell
s from patients with inflammatory lesions expressed CD44V6- and CD44V9
-containing CD44 isoforms in vivo, suggesting that CD44V expression is
associated with differentiation of monocytes to tissue macrophages in
vivo in inflammatory sites. Taken together, our data demonstrate that
PB monocytes, but not T or B lymphocytes, acquire the ability to bind
HA and up-regulate CD44V expression after in vitro culture.